{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:58:49Z","timestamp":1780318729814,"version":"3.54.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Alopecia areata (AA) is a nonscarring alopecia with an estimated global prevalence of 2% and limited data on the efficacy of current treatment. Clinical practice guidelines (CPGs) provide recommendations based on best available evidence. It is unclear how many AA CPGs are available globally.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To systematically search for and identify CPGs on AA and to critically appraise their quality using validated tools.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a literature search to identify CPGs published between October 2014 and April 2021, using the following databases: MEDLINE, Embase, National Institute for Health and Care Excellence (NICE), Guidelines International Network, Emergency Care Research Institute guidelines trust, Australian CPGs, Turning Research Into Practice database and DynaMed. The systematic review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses framework. Three critical appraisal tools were used: Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument, Lenzer\u2019s red flags and United States Institute of Medicine\u2019s (IOM) criteria of trustworthiness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, six AA CPGs from seven manuscripts (one CPG was in two parts published in separate papers) were included. The majority (four of six) of the CPGs focused on treatment. Four CPGs (total of five papers) were in English and two CPGs were only available in the original language (one Russian and one Japanese). All AA CPGs demonstrated low quality in several domains in the AGREE II appraisal, including stakeholder involvement and applicability, with the latter being deemed the worst domain for all CPGs, with an average of 29%. The mean (SD) number of Lenzer\u2019s red flags for the included CPGs was 3.4 (1.5) out of a total of 8 possible red flags, while the IOM criteria showed 1.6 (0.8) \u2018fully met\u2019 criteria and 3.1 (1.2) \u2018not met\u2019 out of a total of 9 criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We found a limited number of AA CPGs, all of which had significant methodological deficiencies. We encourage guideline development groups to use validated checklists\/tools to develop reliable and trustworthy CPGs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llac025","type":"journal-article","created":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T17:57:33Z","timestamp":1673805453000},"page":"100-107","source":"Crossref","is-referenced-by-count":10,"title":["Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a systematic review of alopecia areata clinical practice guidelines"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-8377","authenticated-orcid":false,"given":"Leila","family":"Asfour","sequence":"first","affiliation":[{"name":"Sinclair Dermatology and Clinical Trials Centre , Melbourne, VIC , Australia"},{"name":"The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-8634","authenticated-orcid":false,"given":"Marianne","family":"De Brito","sequence":"additional","affiliation":[{"name":"The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre , Manchester , UK"},{"name":"Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2094-0556","authenticated-orcid":false,"given":"Ali","family":"Al-Janabi","sequence":"additional","affiliation":[{"name":"The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre , Manchester , UK"},{"name":"Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-7202","authenticated-orcid":false,"given":"William W Y","family":"Haw","sequence":"additional","affiliation":[{"name":"The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre , Manchester , UK"},{"name":"Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Johnson","sequence":"additional","affiliation":[{"name":"Alopecia UK , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-6286","authenticated-orcid":false,"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[{"name":"Unit for Population-Based Dermatology Research, St John\u2019s Institute of Dermatology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust"},{"name":"Department of Population Health Sciences, King\u2019s College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-074X","authenticated-orcid":false,"given":"Zenas Zee Ngai","family":"Yiu","sequence":"additional","affiliation":[{"name":"The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre , Manchester , UK"},{"name":"Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"2023100307122149200_llac025-B1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/jidsymp.2013.4","article-title":"Overview of alopecia areata","volume":"16","author":"Hordinsky","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2023100307122149200_llac025-B2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bjd.20628","article-title":"The epidemiology of alopecia areata: a population-based cohort study in UK primary care","volume":"186","author":"Harries","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023100307122149200_llac025-B3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2023100307122149200_llac025-B4","author":"Institute for Health Metrics and Evaluation. Global Burden of Disease Results"},{"key":"2023100307122149200_llac025-B5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2023100307122149200_llac025-B6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt","year":"2005","journal-title":"BMJ"},{"key":"2023100307122149200_llac025-B7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/jidsymp.2013.18","article-title":"Health-Related Quality of Life (HRQoL) in alopecia areata patients \u2013 a secondary analysis of the National Alopecia Areata Registry Data","volume":"16","author":"Shi","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2023100307122149200_llac025-B8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5694\/mja13.10895","article-title":"Alopecia areata and suicide of children","volume":"200","author":"Sinclair","year":"2014","journal-title":"Med J Aust"},{"key":"2023100307122149200_llac025-B9","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/jidsymp.2013.14","article-title":"Current treatment of alopecia areata","volume":"16","author":"Shapiro","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2023100307122149200_llac025-B10","doi-asserted-by":"crossref","first-page":"e1-13","DOI":"10.1111\/ajd.12913","article-title":"Systemic treatments for alopecia areata: A systematic review","volume":"60","author":"Lai","year":"2019","journal-title":"Australas J Dermatol"},{"key":"2023100307122149200_llac025-B11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/17512433.2020.1702878","article-title":"JAK inhibition in the treatment of alopecia areata \u2013 a promising new dawn?","volume":"13","author":"Ismail","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2023100307122149200_llac025-B12"},{"key":"2023100307122149200_llac025-B13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/intqhc\/mzv115","article-title":"Guide to clinical practice guidelines: the current state of play","volume":"28","author":"Kredo","year":"2016","journal-title":"Int J Qual Health Care"},{"key":"2023100307122149200_llac025-B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjd.18951","article-title":"All aboard the BJD for global dissemination of high-quality dermatology clinical practice guidelines","volume":"183","author":"Yiu","year":"2020","journal-title":"Br J Dermatol"},{"key":"2023100307122149200_llac025-B15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/bjd.20428","article-title":"Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines","volume":"185","author":"Haw","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023100307122149200_llac025-B16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","article-title":"AGREE II: advancing guideline development, reporting, and evaluation in health care","volume":"51","author":"Brouwers","year":"2010","journal-title":"Prev Med"},{"issue":"f5535","key":"2023100307122149200_llac025-B17","article-title":"Ensuring the integrity of clinical practice guidelines: a tool for protecting patients","volume":"347","author":"Lenzer","year":"2013","journal-title":"BMJ"},{"issue":"Suppl","key":"2023100307122149200_llac025-B18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.abd.2020.05.006","article-title":"Consensus on the treatment of alopecia areata \u2013 Brazilian Society of Dermatology","volume":"95","author":"Ramos","year":"2020","journal-title":"An Bras Dermatol"},{"key":"2023100307122149200_llac025-B19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","article-title":"The Alopecia Areata Consensus of Experts (ACE) study: results of an international expert opinion on treatments for alopecia areata","volume":"83","author":"Meah","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2023100307122149200_llac025-B20","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaad.2020.09.028","article-title":"The Alopecia Areata Consensus of Experts (ACE) study part II: results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata","volume":"84","author":"Meah","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2023100307122149200_llac025-B21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ajd.12941","article-title":"Treatment of alopecia areata: an Australian expert consensus statement","volume":"60","author":"Cranwell","year":"2019","journal-title":"Australas J Dermatol"},{"key":"2023100307122149200_llac025-B22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.23736\/S0392-0488.19.06458-7","article-title":"Italian Guidelines in diagnosis and treatment of alopecia areata","volume":"154","author":"Rossi","year":"2019","journal-title":"G Ital Dermatol Venereol"},{"key":"2023100307122149200_llac025-B23","first-page":"2741","article-title":"Japanese Dermatological Association's guidelines for the management of alopecia areata","volume":"127","author":"Tsuboi","year":"2017","journal-title":"Jpn J Dermatol"},{"key":"2023100307122149200_llac025-B24"},{"key":"2023100307122149200_llac025-B25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.20972","article-title":"Global Guidelines in Dermatology Mapping Project (GUIDEMAP) \u2013 a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?","volume":"186","author":"Arents","year":"2022","journal-title":"Br J Dermatol"},{"key":"2023100307122149200_llac025-B26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjd.20712","article-title":"Alopecia areata: progress, but who pays?","volume":"186","author":"Sinclair","year":"2022","journal-title":"Br J Dermatol"},{"key":"2023100307122149200_llac025-B27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1586\/edm.11.53","article-title":"Treatment options for alopecia areata","volume":"6","author":"Gregoriou","year":"2011","journal-title":"Expert Rev Dermatol"},{"issue":"Suppl","key":"2023100307122149200_llac025-B28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.17601","article-title":"Current controversies in trichology: a European expert consensus statement","volume":"35","author":"Meyer-Gonzalez","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100307122149200_llac025-B29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bjd.15810","article-title":"Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership","volume":"178","author":"Macbeth","year":"2018","journal-title":"Br J Dermatol"},{"key":"2023100307122149200_llac025-B30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llac025\/48716025\/llac025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/2\/100\/51826358\/llac025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/2\/100\/51826358\/llac025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:12:43Z","timestamp":1696317163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/2\/100\/6765004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2023,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llac025","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,10,21]]}}}